Creative Planning
SLS icon

Creative Planning’s SELLAS Life Sciences SLS Stock Holding History

Creative Planning’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.04M Buy
70,643
+30,072
+74% +$208K ﹤0.01% 2603
2026
Q1 		$172K Buy
+40,571
New +$181K ﹤0.01% 3786
2017
Q3 		– Hold
0
– – – 3426
2017
Q2 		– Hold
0
– – – 4808
2017
Q1 		– Sell
-1
Closed -$1.66K – 4880
2016
Q4 		$2K Buy
+1
New +$5.82K ﹤0.01% 4300

Other funds holding SLS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $250B AUM 21.32% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Creative Planning's SLS Position: Q2 2026 in Review

Creative Planning increased its SELLAS Life Sciences (SLS) stake by 74% in Q2 2026, buying an estimated $208K and bringing the position to 70,643 shares worth $1.04M. The position accounts for ﹤0.01% of the portfolio, ranked #2603.

Creative Planning first reported a position in SLS in Q4 2016 and has held it in 3 quarters since. 192 funds tracked by Wall St. Rank hold SLS as of Q2 2026.

  • Creative Planning held 70,643 shares of SELLAS Life Sciences worth $1.04M as of Q2 2026.
  • Creative Planning bought 30,072 SELLAS Life Sciences shares in Q2 2026, an estimated $208K.
  • SELLAS Life Sciences made up ﹤0.01% of Creative Planning's portfolio in Q2 2026, its #2603 holding.
  • Creative Planning first reported a position in SELLAS Life Sciences in Q4 2016 and has held it in 3 quarters since.
  • 192 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2026.

Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.